IP Verse

Glenmark Life Sciences Limited opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Amorphous Lercanidipine Hydrochloride

Applicant:

Opposition Date:

Nov 13, 2019

Patent:

Grant Date:

Mar 23, 2022

Title:

Process For Preparation Of Apremilast

Oppositions:

Patent Number	Title	Applicant	Opposition Date
EP1856051	Amorphous Lercanidipine Hydrochloride	RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.	Nov 13, 2019

Patent Number	Grant Date	Title	Total Oppositions
EP3341359	Mar 23, 2022	Process For Preparation Of Apremilast	1

HAMM&WITTKOPP PATENTANWALTE PARTMBB

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.

RECORDATI IRELAND LIMITED

Feel free to send us a message here and we will get back to you